Thinking about buying stock in T2 Biosystems, Limbach Holdings, Ebet, Archer Aviation, or Novo Integrated Sciences?

Zynerba Pharmaceuticals Inc

Change company Symbol lookup

Select an option...

ZYNE Zynerba Pharmaceuticals Inc

PDO PIMCO Dynamic Income Opportunities Fund

BOCT Innovator U.S. Equity Buffer ETF™ October

BAC Bank of America Corp

YARIY Yara International ASA

XOM Exxon Mobil Corp

XLF Financial Select Sector SPDR® Fund

XFLT XAI Octagon Floating Rate & Alternative Income Term Trust

WPC WP Carey Inc

WMT WALMART STORES INC

Health Care : Pharmaceuticals | Small Cap Value

Company profile

Zynerba Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders. The Company is engaged in improving the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome (FXS), and chromosome 22q11.2 deletion syndrome (22q). It is focused on using cannabinoids for treating behavioral symptoms of FXS and 22q. It is developing Zygel (ZYN002), a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery and manufactured without the presence of tetrahydrocannabinol (THC). It uses a patent protected formulation containing ethanol and propylene glycol as solubilizing agents and Transcutol HP as a permeation enhancer. Zygel is an investigational drug product in development for the potential treatment of behavioral symptoms associated with FXS, 22q, and autism spectrum disorder (ASD).

Thinking about buying stock in T2 Biosystems, Limbach Holdings, Ebet, Archer Aviation, or Novo Integrated Sciences?

9:31 am ET August 21, 2023 (PR Newswire) Print

InvestorsObserver issues critical PriceWatch Alerts for TTOO, LMB, EBET, ACHR, and NVOS.

https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

-- TTOO: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=TTOO&prnumber=082120230

-- LMB: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=LMB&prnumber=082120230

-- EBET: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=EBET&prnumber=082120230

-- ACHR: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ACHR&prnumber=082120230

-- NVOS: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=NVOS&prnumber=082120230

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

https://c212.net/c/img/favicon.png?sn=CG88866&sd=2023-08-21

View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-t2-biosystems-limbach-holdings-ebet-archer-aviation-or-novo-integrated-sciences-301905573.html

SOURCE InvestorsObserver

https://rt.newswire.ca/rt.gif?NewsItemId=CG88866&Transmission_Id=202308210931PR_NEWS_USPR_____CG88866&DateId=20230821

COMTEX_438808489/1005/2023-08-21T09:31:26